Trafalgar International (GCAN) Cash from Operations (QoQ) (2017 - 2026)
Trafalgar International (GCAN) Cash from Operations (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.87% |
| Dec 31, 2025 | -350.63% |
| Sep 30, 2025 | 72.53% |
| Jun 30, 2025 | -74.82% |
| Mar 31, 2025 | -127.00% |
| Dec 31, 2024 | 72.75% |
| Sep 30, 2024 | 63.20% |
| Jun 30, 2024 | -30.56% |
| Mar 31, 2024 | -14.88% |
| Dec 31, 2023 | 20.73% |
| Sep 30, 2023 | -281.41% |
| Jun 30, 2023 | 41.52% |
| Mar 31, 2023 | 3.08% |
| Dec 31, 2022 | 13.75% |
| Sep 30, 2022 | 60.80% |
| Jun 30, 2022 | -467.84% |
| Mar 31, 2022 | 87.40% |
| Dec 31, 2021 | -8.63% |
| Sep 30, 2021 | -92.03% |
| Jun 30, 2021 | 18.25% |